The atherogenic 7-oxysterols, 7-ketocholesterol (7-KC) and 7b-hydroxycholesterol (7bOHC), can directly impair arterial function. Inter-conversion of 7-KC and 7bOHC has recently been shown as a novel role for the glucocorticoid-metabolizing enzyme 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1). Since this enzyme is expressed in vascular smooth muscle cells, we addressed the hypothesis that interconversion of 7-KC and 7bOHC by 11b-HSD1 may contribute to regulation of arterial function.
Introduction
Pro-atherogenic 7-oxysterols form a large component (40%) of oxidized LDL (oxLDL), of which 7-ketocholesterol (7-KC) contributes w30% [1] . 7-KC is toxic to cells in the vessel wall, and can impair arterial function ex vivo [2] . Indeed, 7-KC and its metabolite 7b-hydroxycholesterol (7bOHC) inhibited endothelium-dependent, acetylcholine-induced relaxation of rabbit aortic rings in vitro [2] . In human umbilical vein endothelial cells (HUVECs), 7bOHC and 7-KC reduced the histamine-activated release of nitric oxide [3] . This inhibition of endothelial function by 7-oxysterols appears to be independent of their cytotoxic effects [4] , but its mechanism is unclear. Importantly, 7-KC and 7bOHC differ in their proatherogenic potential, with 7-KC implicated as the major proinflammatory and cytotoxic oxysterol [5] . However, any differences between the functional effects of 7-KC and 7bOHC in the vasculature have not been addressed.
The balance between 7-KC and 7bOHC in tissues may be actively modulated. Recently, a novel route of metabolism of 7-oxysterols has been described, involving the enzyme 11b-hydroxysteroid dehydrogenase (11b-HSD) type 1. The primary role of 11b-HSD1 is to catalyse the pre-receptor generation of glucocorticoids, allowing tissue-specific amplification of glucocorticoid receptor activation [6] . Inactivation of glucocorticoids is catalysed by the type 2 isozyme of 11b-HSD (11b-HSD2) [7] . It is becoming increasingly apparent that 7-oxysterols are alternative substrates for 11b-HSD1 [8, 9] , and inhibition of the enzyme can result in accumulation of 7-KC [10] . Since both isozymes of 11b-HSD are present in the arterial wall [11e14], where they are able to inter-convert glucocorticoids [15] , it is conceivable that inter-conversion of 7-oxysterols by these enzymes has a role in modulating vascular function.
We used mice with targeted disruption of the 11b-HSD1 gene (Hsd11b1) to investigate the hypothesis that 11b-HSD1 metabolises 7-oxysterols in the arterial wall, thus influencing 7-KC-and 7bOHC-mediated modulation of arterial function.
Methods

Chemicals and stock solutions
All solvents were HPLC grade (Fisher, Hemel Hempstead, UK) and were prepared containing an anti-oxidant (0.01% w/v butylated hydroxytoluene (BHT)) to prevent oxidative degradation of the lipids [3] . Steroids and oxysterols were from Steraloids (Newport, Rhode Island, USA), derivatization reagents from Fluka (Buchs, Switzerland), tissue culture reagents from Lonza (Reading, UK) and other chemicals from Sigma-Aldrich (Poole, Dorset, UK). Deuterium-labelled internal standards for GCMS were obtained from CDN Isotopes (Qmx Laboratories, Essex, UK). Stock solutions (30 mg/ml in ethanol with 250 mg/ml BHT) of 7-KC, 7bOHC and 7aOHC (an optical isomer of 7bOHC) were freshly prepared as required. All steroids were prepared in 100% ethanol. Working solutions for tissue culture were prepared in standard Dulbecco's modified Eagle's medium (DMEM). Working solutions (25 mM 7-KC; 20 mM 7bOHC) for myography were prepared by diluting the appropriate stock solution in DMEM without L-Arginine (Arg) or phenol red, but containing 1% charcoal-stripped foetal calf serum. These were the maximum concentrations of 7-oxysterols that could be achieved without sample precipitation. The final concentration of vehicle (ethanol with 250 mg/ml BHT) was <0.2%.
Animals
Male mice (age 8e16 weeks) homozygous for disrupted alleles of 11b-HSD1 (Hsd11b1 À/À ) [16] or 11b-HSD2 (Hsd11b2 À/À ) [7] , on a C57Bl6/J background [12] were bred in-house. Controls were ageand sex-matched C57Bl6/J mice bred in-house [7, 16] . Mice were maintained on standard chow diet and tap water ad libitum, under a 16 h/8 h light/dark cycle at 21e24 C. All procedures were performed under UK Home Office guidelines of humane care and [17, 18] animals were culled by cervical dislocation at 10.00 h. Plasma (1 ml) was collected from 2e3 mice in EDTA-coated (1.6 mg/ ml) vials (Sarstedt, Monovette) and separated by centrifugation (2000Â g, 4 C, 15 min), and an aliquot of BHT was added (50 mg/ 5 ml). Tissues were snap-frozen and stored at À80 C until use.
Aortae for functional investigation were removed from mice, placed in PBS (37 C), cleaned of peri-adventitial fat and used for myography. Aortae for oxysterol analysis were processed as described below.
Functional effects of 7-oxysterols on isolated mouse aortic rings
Thoracic aortae were isolated from male C57Bl6/J mice (age 8e 10 weeks, n ¼ 12) and cut into four rings (2 mm in length). These were either used immediately for short-term (4 h), or incubated in a 24 well plate for extended (24 h ), exposure to 7-oxysterols. For short-term exposures, aortic rings were mounted on intra-luminal wires in a small vessel wire myograph [19, 20] containing DMEM without L-Arg (37 C, continuously perfused with 95%O 2 : 5% CO 2 ) [14] . After the vessels had been equilibrated at their optimum resting force they were contracted with KCl (125 mM, 3 times) to confirm viability and then incubated in the presence of: (1) [14] , aortic rings were placed in a 24 well plate and immersed in 1 ml DMEM (without L-Arg) containing either 7-KC (25 mM), 7bOHC (20 mM), or vehicle (ethanol with 50 mg/ml BHT) and incubated overnight in a humidified incubator (37 C; 5% CO 2 ). These vessels were then mounted in a myograph and functional studies performed, as described above, in the continued presence of the appropriate 7-oxysterol or vehicle.
Determination of plasma and aortic levels of 7-oxysterols and cholesterol
Concentrations of cholesterol and 7-oxysterols in the plasma and aortae were quantified by GCMS. Aortae from Hsd11b1 À/À or C57Bl6/J mice were pooled from two animals, washed in PBS containing EDTA (0.5 mM), crushed under liquid nitrogen and homogenized. Protein concentration was determined using Bradford assay (Biorad, UK). Deuterium-labelled ([ 2 H], d 7 ) internal standards (IS) were added (50 ml) and lipids were extracted into chloroform/methanol (2:1, 8 ml) [21, 22] . Samples were purified using Bond Elute Diol columns (100 mg, 1 ml; Varian, UK) [23] and hydrolysed following mild saponification [24, 25] . Oxidized lipids and cholesterol were extracted from neutralized samples (0.35 ml, 20% acetic acid) into diethyl ether (4 ml, 0.01% BHT) and evaporated to dryness under argon. Total cholesterol and 7-oxysterol concentrations were measured by GCMS and corrected for aortic protein levels. 7 -7bOHC was used as an internal standard for quantitation of both 7aOHC and 7bOHC. Argon gas was flushed through all samples and oxysterols were extracted (8 ml, 100Â g, 15 min) from media with a mixture of hexane:2-propanol (60:40) [26] . The organic phases were combined, evaporated under a stream of argon and residues dissolved in chloroform:methanol 
In kidney
Murine kidneys contain both isoforms of 11b-HSD. Homogenates of kidneys from Hsd11b1 À/À mice (which lack 11b-HSD1) were used as a source of murine 11b-HSD2, with kidneys from C57Bl6/J mice as controls. Kidneys were homogenized in phosphate buffer as detailed [10] . Homogenates (400 mg/ml) were incubated with 7-oxysterols (20 mM) and the appropriate cofactor (2 mM): NAD þ or NADP þ for dehydrogenase reactions; NADH or NADPH for reductase reactions.
In all assays conversion of dexamethasone (Dex) and 11-dehydrodexamethasone (11-DHDex; 40 mM) was used as a positive control for confirmation of 11b-HSD isozyme activity [28] .
2.6. Chromatographic analyses 2.6.1. Analysis of 7-oxysterols by gas chromatography/mass spectrometry (GCMS) 7-Oxysterols and cholesterol were converted to trimethylsilyl ether derivatives using a pyridine:hexamethyldisilazan:trimethylchlorosilane mixture (350 ml, 3:2:1, v/v/v) [29, 30] . The derivatized cholesterol metabolites were dissolved in 2% N,O-Bis(trimethylsilyl) trifluoroacetamide (BSTFA) in decane (80 ml) and eluted as follows:
initial temperature 180 C (1 min), increased by 35 C/min until 270 C was achieved (1 min) and then increased by 4 C/min to 300 C (12 min). The oven was then cooled by À10 C/min to 250 C (1 min). The injection temperature was 270 C.
A capillary gas chromatograph (Trace GC, Thermo) was coupled to an ion-trap, Polaris Q (Thermo, Hemel Hempstead, UK) mass spectrometer (MS) and equipped with a BPX5 capillary column . Limits of detection were assigned as 3:1 signal to noise ratio. Compounds were quantified by the ratio of area under peak of interest to area under peak of internal standard against a standard curve.
Quantitation of steroids by high pressure liquid chromatography
Radio-labelled glucocorticoids were separated by reverse phase HPLC (Symmetry C8 column maintained at 35 C; column length, 15 cm, internal diameter 4.6 mm, pore size 5 mm, Waters, Edinburgh, UK) and quantified by on-line liquid scintillation counting (2 ml/ min; GoldFlow, Meridian, Surrey, UK). Total run time was 35 min (elution times of epi-cortisol, 11-dehydrocorticosterone and corticosterone were typically 12 min, 21 min and 31 min, respectively, with mobile phase of water:acetonitrile:methanol (60:15:25) at 1 ml/min). Dex and 11-DHDex were separated using a mobile phase of water:acetonitrile:methanol (55:20:25) at 1 ml/min with typical retention times for epi-cortisol (10 min),11-DHDex (12 min) and Dex (16 min) . UV detection of all steroids was achieved at 240 nm and epi-cortisol was used as an internal standard. Steroids were quantified by the ratio of area under peak of interest to area under peak of internal standard against a standard curve.
Statistical analysis
All data are mean AE standard error of the mean (SEM) where n indicates the number of different animals. Values were compared using unpaired Student's t-tests or 1-way ANOVA with Dunnett's multiple comparison post-tests, as appropriate. All analyses were performed using Graph Pad Prism v5.0 (GraphPad Software Inc. San Diego, USA). Statistical significance was assumed when p < 0.05.
Results
7-KC, but not 7bOHC, alters vascular function in vitro
Short-term exposure (4 h) of aortae from C57Bl6/J mice to 7-KC (25 mM), but not 7bOHC (20 mM), produced a small reduction (p ¼ 0.049) in NA-induced maximum contraction (E max ), but had no effect on the sensitivity (pD 2 ) of this response (Fig. 1A, B ; Table 1A ). 5-HT-mediated contraction was unaltered by exposure to either oxysterol (Table 1A) . Pre-treatment of vessels with either 7-KC or 7bOHC did not alter endothelium-dependent relaxation to ACh (Fig. 1C, D ). An apparent increase in maximal response to endothelium-independent, SNP-mediated vasorelaxation after incubation with either 7-KC (p ¼ 0.05) or 7bOHC (p ¼ 0.08) was of borderline statistical significance (Fig. 1E, F) .
Long-term (24 h; Fig. 2 ) exposure of aortae from C57Bl6/J mice to 7-KC (25 mM), but not 7bOHC (20 mM), produced a reduced maximum contraction (E max , p ¼ 0.049), but no change in sensitivity (pD 2 ) to NA ( Fig. 2A, B ; Table 1 B) . Prolonged incubation with either 7-oxysterol had no effect on 5-HT-mediated contraction or endothelium-dependent (Fig. 2C, D) or -independent (Fig. 2E, F 3.3. 7-Oxysterols are metabolized by 11b-HSD1 but not by 11b-HSD2
As expected [15] , glucocorticoids were inter-converted by incubation with intact mouse aortic rings. The velocity of reduction of 11-dehydrocorticosterone to corticosterone (Fig. 3A) proceeded considerably (w10Â) faster than the dehydrogenation of corticosterone to 11-dehydrocorticosterone. Reduction of 11-dehydrocorticosterone was attenuated in mice lacking 11b-HSD1, whereas deletion of this enzyme produced only a small (though significant) increase in the dehydrogenation of corticosterone (to 11-dehydrocorticosterone) (Fig. 3A) . The oxysterols 7-KC and 7bOHC were also inter-converted by incubation with intact mouse aortic rings. In contrast to glucocorticoids, however, the velocities of reduction of 7-KC (to 7bOHC) and of dehydrogenation of 7bOHC (to 7-KC) were similar following incubation with mouse aortic rings (Fig. 3B) . Genetic disruption of Hsd11b1 significantly reduced the velocity of conversion of both 7-KC and 7bOHC (Fig. 3B) , with 96 AE 6% of added substrates being recovered. 7-KC was not interconverted with 7aOHC in aortic rings (data not shown).
Hsd11b1 À/À mouse kidney homogenates (a rich source of 11b-HSD2; [31] ) were used to determine whether 7-oxysterols are metabolised by this isozyme. As with the aortic rings, conversion of glucocorticoids was used as a positive control for activity of 11b-HSD2 [14, 27] . As anticipated, glucocorticoids were metabolized by mouse renal homogenates with preferential generation of 11-DHDex from Dex (oxidation; not shown). In contrast, renal homogenates did not inter-convert any of the 7-oxysterols (7aOHC, 7bOHC or 7-KC). Unrecovered substrate was w3% or lower for each compound (7aOHC, 1.9 AE 0.7%; 7bOHC, 3.2 AE 0.3%; KC, 2.1 AE 0.3%).
Discussion
This study shows for the first time that 11b-HSD1, but not 11b-HSD2, catalyses the conversion of 7-oxysterols in the vascular wall. Previous work has shown that murine and human 11b-HSD1 Fig. 1 . Short-term (4 h) exposure to 7-ketocholesterol induces agonist-specific functional changes in isolated mouse aorta. Endothelium-intact aortic rings from C57Bl6/J mice were incubated (4 h) with 7-ketocholesterol (7-KC, 25 mM open squares) or 7b-hydroxycholesterol (7bOHC, 20 mM, open squares) and compared with vehicle (ethanol containing 50 mg/ ml butylated hydroxytoluene)-treated control (filled squares). Incubation with 7-KC (A), but not 7bOHC (B), produced a small reduction of noradrenaline (NA)-mediated contraction (p ¼ 0.04). Incubations had no effect on acetylcholine (ACh)-mediated relaxation (C, D) whereas 7-KC (E) (but not 7bOHC (F)), produced a trend towards increased sodium nitroprusside (SNP)-mediated relaxation (p ¼ 0.054). Relaxations were expressed on a scale where the response to 5-HT represented 100% and return to baseline was expressed as 0%. All points represent mean AE SEM, compared by 1-way ANOVA with Tukey's post hoc test, n ¼ 6e8. converts 7-KC to 7bOHC in the liver and in cultured adipocytes [8, 9] . We provide evidence that murine 11b-HSD1 reduces 7-KC to 7bOHC in the vessel wall but, furthermore, that it also oxidizes 7bOHC to 7-KC. Use of Hsd11b1 À/À mice confirmed that 11b-HSD1 was the sole enzyme responsible for metabolism of 7-KC and 7bOHC in the aortic wall and that deletion of 11b-HSD1 alters vascular 7-oxysterol concentrations. Functional investigations showed differential effects of 7-KC and 7bOHC on vascular function, suggesting that this 11b-HSD1-mediated inter-conversion of 7-oxysterols may influence 7-KC-mediated inhibition of arterial contraction. 7-KC and 7bOHC have both been shown previously to inhibit endothelium-dependent vasorelaxation [32] , cause endothelial cell death, and induce production of radical oxygen species [17, 33] . This is consistent with the ability of oxidized lipids to impair the endothelium-dependent relaxation of aortic segments from hyperlipidaemic mice [34] . The lack of impact of exposure to oxysterols on endothelium-dependent relaxation was surprising given the previous indications that both 7-KC and 7bOHC inhibit endothelial function [2, 3, 32] ex vivo. One possible explanation for lack of effect on vasorelaxation is the use of a low concentration of 7-oxysterol (20e25 mM) compared with previous studies (180e 270 mM; [2, 3, 32] ). The concentrations used for our investigations were the highest we could achieve without precipitation and are consistent with that used (25 mM) to show 7-oxysterol-mediated smooth muscle apoptosis in vitro [35] . Furthermore, a recent investigation using high concentrations of 7-KC (205 mM) found no effect of ex vivo incubation on ACh-mediated relaxation of mouse aorta [36] .
Intriguingly at the concentrations used in this investigation, there was an inhibition of smooth muscle cell contraction by 7-KC that was not observed with 7bOHC. The mechanism involved is unclear but the effect was selective for noradrenaline, suggesting an impairment in the a 1 -adrenoceptor signalling pathway.
Impaired contractility is consistent with 7-KC at this concentration having detrimental effects on vascular smooth muscle cells [35] . These results suggest, therefore, that the balance of 7-KC and 7bOHC may have functional and structural implications in the arterial wall.
The concentrations of 7-oxysterols in the vessels of C57Bl6/J mice are consistent with those reported previously in human plasma and vessels [1, 24] . Since circulating 7-oxysterols can be sequestered by cells in the vessel wall [37] , we assessed the potential of vascular 11b-HSD1 to inter-convert 7-oxysterols in this tissue. Plasma 7-oxysterol levels were not altered in Hsd11b1 À/À mice although total plasma cholesterol was substantially lower. Consistent with previous reports of reduced intra-vascular cholesterol accumulation with inhibition of 11b-HSD1 [38] , we found lower levels of all 7-oxysterols in the aortae of Hsd11b1 À/À mice. It was, therefore, difficult to assess intra-vascular 7-KC:7bOHC ratios, since 7-KC levels in particular were near to the detection limit, but the data suggest that 7-KC levels are disproportionately reduced in Hsd11b1 À/À mice, consistent with the enzyme acting predominantly as an oxidase (converting 7bOHC to 7-KC) in vivo.
The ex vivo incubation of aortic rings described here has not previously been used to assess inter-conversion of 7-oxysterols. This approach confirmed that the stability of 7-oxysterols can be preserved during incubation, as both 7-KC and 7bOHC were successfully recovered from DMEM. It had been postulated that 7-oxysterols may be taken up by the vessels during incubation but the percentage recovery of 7-oxysterols from reaction mixtures did not support this. Preparation of concentrated stock solutions of the 7-oxyserols proved unexpectedly difficult, despite using published methodology [3] , with oxysterols precipitating at high concentrations. Based on our own experiences and advice from other groups 7-oxysterol solutions were prepared in DMEM containing FCS containing an antioxidant (BHT; to prevent oxidative degradation of the lipids [3] ). It is unlikely that BHT would have a detrimental effect on vascular function as it did not alter histamine-induced NO production in cultured HUVECs [32] .
Ex vivo assays clearly demonstrated that incubation of 7-oxysterols with mouse aortic rings results in the conversion of 7bOHC to 7-KC and 7-KC to 7bOHC, but not inter-conversion of 7aOHC and 7-KC. This is consistent with results generated in rats [9, 10] and humans [39] but contrasts with the demonstration that 11b-HSD1 in hamsters can inter-convert 7aOHC and 7-KC [40] . The ability of 11b-HSD1 to inter-convert 7-oxysterols explains why carbenoxolone, a non-selective 11b-HSD inhibitor, attenuates 7-oxysterol metabolism in rat hepatic microsomes [10] . Interestingly, in contrast to the predominant reductase direction (11-dehydrocorticosterone to corticosterone) shown for metabolism of glucocorticoids, murine vascular 11b-HSD1 showed similar activity as both reductase (7bOHC to 7-KC) and dehydrogenase (7-KC to 7bOHC) for inter-conversion of oxysterols, consistent with previous reports in liver [9, 39] . Under these assay conditions, the reaction velocity for inter-conversion of oxysterols was considerably (approximately 10-fold) higher than for reduction of 11-dehydrocorticosterone. This contrasts with the demonstration of similar reaction velocities observed in other studies [9, 40] and is likely to be a consequence of study design as substrate concentrations were higher (w800Â) for the oxysterols than for the glucocorticoids.
Residual metabolism of glucocorticoids in aortae from Hsd11b1 À/À mice is consistent with vascular 11b-HSD2 expression [14, 20] . Virtually no residual inter-conversion of 7bOHC and 7-KC was observed in aortae from mice lacking 11b-HSD1. Lack of 7-oxysterol metabolism by 11b-HSD2 was confirmed using kidney homogenates (since the kidney is rich in 11b-HSD2 [15] ; using kidneys from Hsd11b1 À/À mice ensured that there was no interference from this isozyme). This finding is consistent with the previous attribution of 7-oxysterol metabolism solely to the action of 11b-HSD1 in hamster [40] , rat [9, 10] , guinea pig [9, 41] and human [39] . There was, however, a notable loss of substrate in the reaction mixtures; suggesting incomplete recovery of substrate, non-enzymatic degradation, or formation of alternative products [42] . There was no loss of substrate in blank samples (containing buffer but no tissue homogenate), confirming chemical stability of 7-oxysterols during the incubation.
Direct action on the cells of the arterial wall may not present the only mechanisms through which oxysterols can influence regulation of arterial function and structure. Previous work in our group [43] has indicated that the ability of oxysterols to act as substrates for 11b-HSD1 also makes them potential competitive inhibitors of glucocorticoid metabolism. This presents the possibility that endogenous 7-oxysterols contribute to regulation of 11b-HSD1-dependent glucocorticoid generation. Glucocorticoids can interact directly with the arterial wall to enhance vasoconstriction [44] , impair endothelium-dependent relaxation [45] , inhibit angiogenesis [27] and reduce vascular lesion formation. There is increasing evidence that these interactions are regulated by the activity of 11b-HSD1 [27, 38] . However, it is notable that no systematic difference in vascular function has been observed in vessels from Hsd11b1 À/À mice [20] , so whether alterations in either 7-oxysterol or glucocorticoids influences physiological vascular function remains uncertain. Perhaps interactions of oxysterols with 11b-HSD1 are more important in pathology. In healthy individuals, the maximum concentrations of 7-oxysterols [46, 47] are lower than those in patients with atherosclerosis who may have levels of 7-oxysterols in the micromolar range [1] . It is plausible that inhibition of 11b-HSD1-mediated glucocorticoid generation in conditions of 7-oxysterol excess may have an indirect impact on arterial function and remodelling. Metabolism of 7-oxysterols by 11b-HSD1 may also have implications for the development of new therapies. Selective 11b-HSD1 inhibition prevents atherosclerosis [38] and is being developed for treatment of cardiovascular risk factors [48] , but the mechanisms responsible for this atheroprotective effect have not been demonstrated. It is conceivable that the beneficial effects of 11b-HSD1 inhibition are a consequence of prevention of 7-oxysterol interconversion as well as glucocorticoid metabolism.
Conclusions
11b-HSD1 influences 7-oxysterol concentrations within the arterial wall. By altering the balance of 7-ketocholesterol and 7b-hydroxycholesterol, 11b-HSD1 may modulate their specific effects on vascular function, especially in disease states in which oxysterol levels are increased. Fig. 3 . 11b-HSD1 catalyses reduction of 7-Ketocholesterol (7-KC) and dehydrogenation of 7b-Hydroxycholesterol (7bOHC) in isolated mouse aorta. Incubation with mouse aortic rings (24 h; 37 C; 5% CO 2 ) resulted in (A) metabolism of glucocorticoids (n ¼ 10); reduction of 11-dehydrocorticosterone (11DHC; 30 nM) to form corticosterone (Cort) was reduced, but not abolished, in aortae from 11b-HSD1 À/À mice. Low levels of dehydrogenation of Cort (30 nM; to form 11DHC) were detected in mouse aorta. Surprisingly this was slightly (but significantly) increased in the absence of 11b-HSD1. (B) Both 7-oxysterols (1 mM) were metabolized following exposure to mouse aortic rings (n ¼ 6) but, in contrast to glucocorticoids, both dehydrogenation (conversion of 7bOHC to 7-KC) and reduction (7-KC to 7bOHC) reactions were virtually abolished in arteries lacking 11b-HSD1 (11b-HSD1 À/À ). Data are mean AE SEM, and were compared using unpaired Student's t-test, **p < 0.01, ***p < 0.001 vs velocity of the same reaction in tissues from C57Bl/6 mice.
